Last reviewed · How we verify
NCT04683263
Immediate and Mid-term Effect of a Natural Topical Product in Patients With Musculoskeletal Pain
NA trial testing Placebo in Musculoskeletal Pain in 200 participants. Completed in 20 December 2019.
20 December 2019
Quick facts
| Lead sponsor | Uriach Consumer Healthcare |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 1 June 2019 |
| Primary completion | 20 December 2019 |
| Estimated completion | 20 December 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Placebo
- Fisiocrem
Conditions studied
- Musculoskeletal Pain — all drugs for Musculoskeletal Pain →
- Chronic Pain — all drugs for Chronic Pain →
- Joint Pain — all drugs for Joint Pain →
- Stiffness of Unspecified Joint, Not Elsewhere Classified — all drugs for Stiffness of Unspecified Joint, Not Elsewhere Classified →
Sponsor
Uriach Consumer Healthcare
Who can join
18 and older, any sex, with Musculoskeletal Pain or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Musculoskeletal pain is a common affection due to ageing, sedentarism and intense exercise practice causing acute and chronic injuries. The main objective of this trial is to prove efficacy of a natural topical composition containing Arnica montana, Hypericum perforatum, Calendula officinalis, Melaleuca sp. and menthol in pain management in adults with acute or chronic pain. This randomized, double-blinded and placebo-controlled trial will include 200 patients with musculoskeletal pain, 100 in the intervention group receiving the topical formula and 100 in the placebo group, who will receive a similar formula without active ingredients. The products will be applied topically twice daily for 14 days in areas with moderate or severe pain. The study objectives are immediate and long-term pain alleviation, stiffness perception joint mobility, and general recovery perception.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04683263
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Musculoskeletal Pain
Currently open trials in the same condition.
- NCT06398847 — Virtual Reality (VR) Self-Hypnosis Software · NA · recruiting
- NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
- NCT07356115 — Association of High PainDETECT Scores With Pain Region and Diagnosis in Patients Attending a Musculoskeletal and Sports · recruiting
- NCT06704061 — Online Yoga vs Acceptance and Commitment Therapy for Treating Chronic Musculoskeletal Pain · NA · recruiting
- NCT07048366 — Mindfulness-based Rehabilitation in a University Museum Setting to Reduce Pain and Improve Quality of Life in Women With · NA · recruiting
Other Uriach Consumer Healthcare trials
Trials by the same sponsor.
- NCT06199128 — Efficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive Patients · completed
- NCT05459272 — Clinical Trial on a Food Supplement With Melatonin and Herbal Products to Improve Sleep Quality · NA · unknown
- NCT05060744 — Efficacy and Speed of Action of a Product to Control Gastric Hydration and Gastroesophageal Reflux · NA · unknown
- NCT04771546 — Efficacy of Intravaginal Carboxymethyl-β-glucan and Polycarbophil on Low-grade Cervical Lesions (GLUCANCIN) · NA · unknown
- NCT04781023 — Efficacy of an Intravaginal Treatment With Carboxymethyl-β-glucan and Polycarbophil in HR-HPV Clearance · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04683263 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uriach Consumer Healthcare
- Last refreshed: 8 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04683263.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing